miR-125b1 |
Decreased in human cancers including glioblastoma, prostate cancer, ovarian cancer and breast cancer |
EST1, ERBB2, ERBB3, Bak1 |
In breast cancer cells, disruption of CTCF binding at the miR-125b1 CpG island correlated with DNA methylation and methylation of histone H3K9 and K27 induces silencing of miR-125b1 expression |
Scott et al., 2007; Zhang et al., 2011; Soto-Reyes et al., 2012
|
miR-375 |
Overexpressed in ERα-positive breast cancer cells |
RASD1 |
In ERα-positive breast cancer cells, miR-375 overexpression was caused by dissociation of CTCF from the miR-375 promoter via loss of epigenetic marks including local DNA hypomethylation and histone H3 K9 methylation |
de Souza Rocha Simonini et al., 2010
|
miR-290 cluster |
miR-290 cluster (miR-290, -291a, -292, -291b, -293, -294 and -295) have been identified as ESC-specific/pluripotency-associated miRNAs |
Rbl2 |
CTCF binds to intragenic enhancer region within the early embryonic miRNA cluster (EEmiRC) and modulates the expression of the EEmiRC |
Houbaviy et al., 2003, 2005; Benetti et al., 2008; Chen et al., 2008; Sinkkonen et al., 2008; Judson et al., 2009; Tata et al., 2011
|